Search for your location and set as default to quickly access your Care Center's information and homepage.
Click questions to expand for more information
Following a thorough safety review, the FDA and CDC recommended that use of the Johnson & Johnson vaccine resume effective April 23, 2021. However, according to the CDC, “women younger than 50 years old should be aware of the rare risk of blood clots with low platelets after vaccination, and that other COVID-19 vaccines are available where this risk has not been seen.”
This action followed a pause in the use of the Johnson & Johnson issued by the FDA and CDC on April 13, 2021. The CDC and FDA recommended the pause out of an abundance of caution, following reports of a rare and severe type of blood clot occurring at a rate of about 7 per 1 million vaccinated women between 18 and 49 years old.
Following the thorough safety review conducted during the pause:
See the full statement here
See the CDC’s guidance on what you need to know if you received the J&J/Janssen vaccine here
At Conviva Care Centers, COVID-19 vaccine safety and your health are of the utmost importance to us.
PER FDA AND CDC GUIDANCE, CONVIVA CARE CENTERS WILL RESUME THE ADMINISTRATION OF THE Johnson & Johnson (Janssen) COVID-19 Vaccine EFFECTIVE APRIL 29, 2021.
Besides reaching out to your doctor, tell the CDC about any adverse effects after getting the COVID-19 vaccine by registering on V-safe. “V-safe is a smartphone-based tool that uses text messaging and web surveys to provide personalized health check-ins after you receive a COVID-19 vaccination. Through v-safe, you can quickly tell CDC if you have any side effects after getting the COVID-19 vaccine. Depending on your answers, someone from CDC may call to check on you and get more information.” Learn more about V-safe After Vaccination Health Checker.